AMGN compared with PRME: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

PRMEPrime Medicine, Inc.

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

PRMEPrime Medicine, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

AMGN

4 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±4.1%▲+4.57%×1.12

Q1 FY26±3.9%▼−4.75%×1.23

Feb 4 '26±3.7%▲+8.15%×2.22

Q3 FY25±3.7%▲+7.81%×2.11

PRME

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±14.2%▼−4.22%×0.30

May 7 '26±15.5%▼−8.65%×0.56

= impliedAMGN realized, solidPRME realized, hatchedOne scale, both sides: full bar = 19%× = |realized| ÷ impliedSource: market data

Q1 FY26

±18.4%

▼−9.23%

×0.50

Q3 FY25±17.6%▼−8.85%×0.50

AMGNAmgen Inc

465.45▼−0.12%· post 467.48· delayed

Mkt cap$251.9BRevenue$10.1BQ2 FY26Revenue$36.8BFY25

PRMEPrime Medicine, Inc.

4.44▼−6.04%· post 4.44· delayed

After hoursNov 2 '26delayed

Mkt cap—Revenue$1MQ2 FY26Revenue$5MFY25

Compare

After hoursNov 2 '26delayed

AMGNAmgen Inc

PRMEPrime Medicine, Inc.

465.45▼−0.12%post 467.48delayed

Price

4.44▼−6.04%post 4.44delayed

$251.9B

Mkt cap

—

Q2 FY26$10.1B

Revenue

$1MQ2 FY26

FY25$36.8B

Revenue

$5MFY25

AMGN465.45▼−0.12%vsPRME4.44▼−6.04%After hoursNov 2 '26delayed